| Dr Matthew Arnfin Taylor, MB, BCH, BAO | |
|
1450 Western Ave Ste 102, Anesthesia Group Of Albany, Albany, NY 12203-3539 | |
| (518) 463-0050 | |
| (518) 207-2973 |
| Full Name | Dr Matthew Arnfin Taylor |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 19 Years |
| Location | 1450 Western Ave Ste 102, Albany, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013169812 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 252187 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saratoga Hospital | Saratoga springs, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Albany Medical College | 1759293111 | 910 |
News Archive
Cancer Research UK has started recruiting patients for a pioneering initiative to demonstrate how genetic tests could be used within the NHS to help match cancer patients to the most appropriate treatment, while building a database of information for research into new targeted therapies.
The European Region is the first in the world to have achieved interruption of indigenous malaria transmission. The number of indigenous malaria cases dropped from 90 712 in 1995 to zero cases in 2015.
Diaverum, one of the world's leading renal care service providers, added the 250th clinic to its growing clinic network throughout Europe, Latin America, Australia, and the Middle East.
Ablynx [Euronext Brussels: ABLX] and Spirogen Ltd. announce a research collaboration to evaluate the potential of a novel anti-cancer drug conjugate combining Spirogen's proprietary cytotoxic drugs, pyrrolobenzodiazepines (PBD), and associated linker technology, with Nanobodies® generated using Ablynx's proprietary technology platform.
America's pharmaceutical research and biotechnology companies are developing 234 medicines for the special health care needs of children, according to a new report released today by the Pharmaceutical Research and Manufacturers of America.
› Verified 8 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629008537 PECOS PAC ID: 1759293111 Enrollment ID: O20031125000386 |
News Archive
Cancer Research UK has started recruiting patients for a pioneering initiative to demonstrate how genetic tests could be used within the NHS to help match cancer patients to the most appropriate treatment, while building a database of information for research into new targeted therapies.
The European Region is the first in the world to have achieved interruption of indigenous malaria transmission. The number of indigenous malaria cases dropped from 90 712 in 1995 to zero cases in 2015.
Diaverum, one of the world's leading renal care service providers, added the 250th clinic to its growing clinic network throughout Europe, Latin America, Australia, and the Middle East.
Ablynx [Euronext Brussels: ABLX] and Spirogen Ltd. announce a research collaboration to evaluate the potential of a novel anti-cancer drug conjugate combining Spirogen's proprietary cytotoxic drugs, pyrrolobenzodiazepines (PBD), and associated linker technology, with Nanobodies® generated using Ablynx's proprietary technology platform.
America's pharmaceutical research and biotechnology companies are developing 234 medicines for the special health care needs of children, according to a new report released today by the Pharmaceutical Research and Manufacturers of America.
› Verified 8 days ago
| Entity Name | Anesthesia Group Of Albany, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598700379 PECOS PAC ID: 5092602458 Enrollment ID: O20040301000885 |
News Archive
Cancer Research UK has started recruiting patients for a pioneering initiative to demonstrate how genetic tests could be used within the NHS to help match cancer patients to the most appropriate treatment, while building a database of information for research into new targeted therapies.
The European Region is the first in the world to have achieved interruption of indigenous malaria transmission. The number of indigenous malaria cases dropped from 90 712 in 1995 to zero cases in 2015.
Diaverum, one of the world's leading renal care service providers, added the 250th clinic to its growing clinic network throughout Europe, Latin America, Australia, and the Middle East.
Ablynx [Euronext Brussels: ABLX] and Spirogen Ltd. announce a research collaboration to evaluate the potential of a novel anti-cancer drug conjugate combining Spirogen's proprietary cytotoxic drugs, pyrrolobenzodiazepines (PBD), and associated linker technology, with Nanobodies® generated using Ablynx's proprietary technology platform.
America's pharmaceutical research and biotechnology companies are developing 234 medicines for the special health care needs of children, according to a new report released today by the Pharmaceutical Research and Manufacturers of America.
› Verified 8 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497921688 PECOS PAC ID: 1759293111 Enrollment ID: O20190320001621 |
News Archive
Cancer Research UK has started recruiting patients for a pioneering initiative to demonstrate how genetic tests could be used within the NHS to help match cancer patients to the most appropriate treatment, while building a database of information for research into new targeted therapies.
The European Region is the first in the world to have achieved interruption of indigenous malaria transmission. The number of indigenous malaria cases dropped from 90 712 in 1995 to zero cases in 2015.
Diaverum, one of the world's leading renal care service providers, added the 250th clinic to its growing clinic network throughout Europe, Latin America, Australia, and the Middle East.
Ablynx [Euronext Brussels: ABLX] and Spirogen Ltd. announce a research collaboration to evaluate the potential of a novel anti-cancer drug conjugate combining Spirogen's proprietary cytotoxic drugs, pyrrolobenzodiazepines (PBD), and associated linker technology, with Nanobodies® generated using Ablynx's proprietary technology platform.
America's pharmaceutical research and biotechnology companies are developing 234 medicines for the special health care needs of children, according to a new report released today by the Pharmaceutical Research and Manufacturers of America.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew Arnfin Taylor, MB, BCH, BAO 1450 Western Ave Ste 102, Anesthesia Group Of Albany, Albany, NY 12203-3539 Ph: (518) 463-0050 | Dr Matthew Arnfin Taylor, MB, BCH, BAO 1450 Western Ave Ste 102, Anesthesia Group Of Albany, Albany, NY 12203-3539 Ph: (518) 463-0050 |
News Archive
Cancer Research UK has started recruiting patients for a pioneering initiative to demonstrate how genetic tests could be used within the NHS to help match cancer patients to the most appropriate treatment, while building a database of information for research into new targeted therapies.
The European Region is the first in the world to have achieved interruption of indigenous malaria transmission. The number of indigenous malaria cases dropped from 90 712 in 1995 to zero cases in 2015.
Diaverum, one of the world's leading renal care service providers, added the 250th clinic to its growing clinic network throughout Europe, Latin America, Australia, and the Middle East.
Ablynx [Euronext Brussels: ABLX] and Spirogen Ltd. announce a research collaboration to evaluate the potential of a novel anti-cancer drug conjugate combining Spirogen's proprietary cytotoxic drugs, pyrrolobenzodiazepines (PBD), and associated linker technology, with Nanobodies® generated using Ablynx's proprietary technology platform.
America's pharmaceutical research and biotechnology companies are developing 234 medicines for the special health care needs of children, according to a new report released today by the Pharmaceutical Research and Manufacturers of America.
› Verified 8 days ago
Dr. Richard Lee Griffith Iii, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 47 New Scotland Ave, Mc-131, Albany Medical College, Anesthesiology, Albany, NY 12208 Phone: 860-481-1396 | |
Dr. Jennifer Jaye Knuth, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave, Department Of Anesthesia, Albany, NY 12208 Phone: 518-262-4302 | |
Brian A. Mchugh, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1450 Western Ave, Suite 102, Albany, NY 12203 Phone: 518-463-0050 Fax: 518-207-2973 | |
David Podrid, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-525-1410 Fax: 518-207-2973 | |
Cindy W. Hughes, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1450 Western Ave, Suite 102, Albany, NY 12203 Phone: 518-463-0050 Fax: 518-207-2973 | |
Andrzej J. Lechowicz, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1450 Western Ave, Suite 102, Albany, NY 12203 Phone: 518-463-0050 Fax: 518-207-2973 |